Back to mobile site

More on ABCL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+5.3% Growth)
- Ratings (8.5 Score)
- Holders

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AbCellera (NQ:ABCL)
Delayed: 12.70 +0.05 (0.40%)
Prev. Close $12.65  
Open$12.74 
52 Wk High$ 
52 Wk Low$ 
Day High$12.93 
Day Low$12.29 
P/E N/A  
EPS$ 
Volume3,382,858 

Friends, Peers and Foes (?): ABSI, SDGR, JAZZ, VRTX, HYFT (more...)

Sep 24, 2026 04:59 AM Goldman Sachs Resumes AbCellera Biologics (ABCL) at Neutral
Sep 16, 2026 04:05 PM AbCellera to present Phase 2 data on menopause drug at IMS congress
Sep 16, 2026 04:05 PM AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
Aug 24, 2026 05:22 PM Form 4 AbCellera Biologics Inc. For: Aug 24 Filed by: Hayden Michael R
Aug 19, 2026 08:56 AM Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
Aug 18, 2026 02:45 PM Form 4 AbCellera Biologics Inc. For: Aug 18 Filed by: Montalbano John S.
Aug 14, 2026 12:04 PM Form 4 AbCellera Biologics Inc. For: Aug 14 Filed by: Booth Andrew
Aug 14, 2026 11:50 AM Form 4 AbCellera Biologics Inc. For: Aug 12 Filed by: Hayden Michael R
Aug 13, 2026 04:36 PM Form 8-K AbCellera Biologics Inc. For: Aug 12
Aug 13, 2026 04:34 PM Form 424B5 AbCellera Biologics Inc.
View All Articles

Entities mentioned with ABCL

View All Entities